FDA sets new date for Eliquis review in atrial fibrillation
US regulator had asked for more data from Pfizer and BMS
Read MoreSection: Regulatory
Vivus expects knockback from EMA for obesity drug
Setback comes despite US approval for Qsiva/Qsymia
Read MoreFDA launches safety probe into Boehringer’s Mirapex
Regulator concerned about potential heart risk link to Parkinson’s disease drug
Read More
Bayer fails to block Indian Nexavar compulsory licence
Loses ‘stay’ appeal against Natco Pharma in Chennai court
Read More
Sweden’s Tomas Salmonson to chair EMA’s CHMP
He replaces Eric Abadie who retired in April
Read More